Iteos Therapeutics Inc
Biotechnology
Healthcare
ITOS
43.24 M shares
NASDAQ US
traded
28 Aug 2025
listed
no
open
10.14
52 week high
17.97
high
10.17
52 week low
0.00
low
10.14
growth
-39.76 %
previous Close
10.13
P/E ratio
-6
market cap
447 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
-78.73 M
-127.46 %
eps
-1.81 %
-126.25 %
eps surprise
-103.78 %
net profit margin
-7872900000.00 %
0.00 %
operating incoming
-66.52 M
-66.22 %
net change in cash
51.29 M
255.71 %
cash on hand
208 M
32.76 %
cost of revenue
0.00 %
top top